Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE – Get Rating)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.26 and traded as low as $0.25. Ampio Pharmaceuticals shares last traded at $0.27, with a volume of 123,033 shares trading hands.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of Ampio Pharmaceuticals in a research report on Friday, April 21st. They issued a “sell” rating for the company.
Ampio Pharmaceuticals Price Performance
The company’s 50-day moving average is $0.26 and its two-hundred day moving average is $0.23. The firm has a market cap of $4.03 million, a P/E ratio of -0.14 and a beta of 1.48.
Institutional Inflows and Outflows
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease.
- Get a free copy of the StockNews.com research report on Ampio Pharmaceuticals (AMPE)
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
- Foot Locker And The Ebbing Tide Of Discretionary Spending
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.